Detalhe da pesquisa
1.
Clinical regressions and broad immune activation following combination therapy targeting human NKT cells in myeloma.
Blood
; 121(3): 423-30, 2013 Jan 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-23100308